0
Startups & Venture·September 21, 2026·1 min read

Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures

Share

Biopharma is starting to pay for AI that plugs directly into existing R&D systems, not just standalone discovery tools. If Mithrl’s “biomedical world model” can sit in the loop with pharma workflows, expect procurement teams to favor vendors that integrate with ELNs, LIMS, and trial stacks out of the box.

Startups & Venture

Aided by AI, young people in China launched 7M+ one-person startups in 2025 to escape a bleak job market, up ~42% from 2024, as they face fierce competition

A 42% jump to 7M+ solo AI businesses in a year is a labor-structure story — AI is turning unemployment into hyper-fragmented micro-entrepreneurship. For operators, this is both a demand pool and a competitor set: expect more niche tools, services, and content from one-person shops, and more pricing pressure at the edges of your product.